Skip to main content

Identification and Validation of Novel Breast Cancer Drugs

Printer-friendly versionPrinter-friendly versionSend by emailSend by email
Award date: 
Aug 26, 2014
Award amount: 
$250,000
Organization name: 
KinoDyn, Inc.
Principal Investigator: 
Dial, Michael
Grant program category: 
Business Financing
Grant program name: 
Small Business Research Loan
Region: 
Research Triangle

KinoDyn, Inc. is a Chapel Hill-based oncology drug development company. The company is built around a proprietary platform technology, which simultaneously maps and quantifies important cellular enzymes, called kinases. We are currently leveraging the platform to discover novel compounds to address challenging cancers including triple negative breast cancer (TNBC).

Fiscal year: 
2015